ARKD-104

N/A

Report date: 2023/05/31 17:42:27
NME

Base Information

Drug NameARKD-104
Drug Alias NameARKD-104
ClassificationSmall molecules
Mechanisms of ActionProgranulin stimulants
TargetsProgranulin
Therapy Area/IndicationsNeurodegenerative DiseasesFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArkuda Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesArkuda Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeurodegenerative DiseasesFrontotemporal Dementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A